Aims and Scope
Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.
Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.
We publish a range of content types including original research articles, reviews, letters, correspondence and comments that elaborate on significant advances in the field and cover topical issues.
Why Publish in Leukemia?
- Ranked in the top quartile of journals worldwide in the fields of oncology and hematology, we publish high quality, peer reviewed original content across all aspects of the research and treatment of leukemia and allied diseases.
- We provide wide exposure and high visibility for your publication through our nature.com platform. We also offer funder-compliant open access options.
- Leading voices in the field across the globe form our expert editorial team, providing attractive turnaround times from first decision to publication.
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2020 peer review performance metrics for Leukemia are shown below:
Average time to decision without external review - 7 days
Average time to decision following external review - 37 days
Average time from submission to acceptance - 119 days
Average time from acceptance to publication - 15 days
Article page views - 1,590,343
Altmetric mentions - 3,105
The 2020 journal metrics* for Leukemia are as follows:
2-year Impact Factor*: 11.528
5-year Impact Factor*: 11.37
Immediacy index*: 4.805
Eigenfactor® score*: 0.04594
Article influence score*: 3.69
JCR Rank*: ONCOLOGY 23/242; HEMATOLOGY 5/76
Journal Citation Score*: 2.22
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2020)
12 issues per year
EBSCO Discovery Service
Summon by ProQuest
Current Contents/Life Sciences
Science Citation Index
Science Citation Index Expanded (SciSearch)
EBSCO Academic Search
EBSCO Advanced Placement Source
EBSCO Biomedical Reference Collection
EBSCO STM Source
EBSCO TOC Premier
ISSN and eISSN
International standard serial number (ISSN): 0887-6924
Electronic international standard serial number (eISSN): 1476-5551.
Leukemia now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.